OREANDA-NEWS. March 15, 2013. The Supreme Arbitration Court of the Russian Federation ruled not to transfer a case to the Presidium of the Supreme Arbitration Court upon a petition of “R-Pharm” CJSC to reconsider the judgment of the Federal Arbitration Court of the Moscow District that “R-Pharm” CJSC and “Irvin-2” Ltd. took part in a bid-rigging collusion for purchasing medicines.

In the ruling the Supreme Arbitration Court stated that the Cassation Court had based its decision on particular circumstances and arguments of the persons participating in the case, to which the Court had given an appropariate legal opinion and reasonably concluded that the Federal Antimonopoly Services validly classified actions of “R-Pharm” CJSC and “Irvin-2” Ltd. as a prohibited agreement.

On 10th October 2012, the Federal Arbitration Court of the Moscow District agreed with FAS arguments that “R-Pharm” CJSC and “Irvin-2” Ltd. violated Clause 2 Part 1 Article 11 of the Federal Law “On Protection of Competition” by participating in the bid-rigging collusion for purchasing medicines.